批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/12/15 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/10/07 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/12/16 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/03/20 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/06/04 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/08/27 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/05/25 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/05/26 |
SUPPL-27(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/05/01 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1997/08/12 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1996/06/21 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1995/02/22 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/03/23 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/03/23 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/03/23 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/03/19 |
SUPPL-17(补充) |
Approval |
Efficacy |
|
|
|
1992/11/10 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1990/10/05 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1987/04/29 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1986/11/14 |
SUPPL-10(补充) |
Approval |
Labeling |
|
|
|
1986/11/14 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1986/08/06 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1986/06/20 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1986/03/18 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1986/03/18 |
SUPPL-6(补充) |
Approval |
Labeling |
|
|
|
1985/08/21 |
SUPPL-3(补充) |
Approval |
Labeling |
|
|
|
1985/08/21 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1984/09/10 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1984/05/04 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:SUFENTANIL CITRATE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 0.05MG BASE/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019050 |
001 |
NDA |
SUFENTA PRESERVATIVE FREE |
SUFENTANIL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
Yes |
Yes |
AP |
1984/05/04
|
RISING |
074413 |
001 |
ANDA |
SUFENTANIL CITRATE |
SUFENTANIL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
No |
No |
AP |
1995/12/15
|
HIKMA |
074534 |
001 |
ANDA |
SUFENTANIL CITRATE |
SUFENTANIL CITRATE |
INJECTABLE;INJECTION |
EQ 0.05MG BASE/ML |
Prescription |
No |
No |
AP |
1996/12/11
|
HOSPIRA |